Global Peptic Ulcer Disease Medication Market Research Report 2026(Status and Outlook)
Drugs for the treatment of peptic ulcers refer to drugs used to treat gastric ulcers and duodenal ulcers, which mainly promote ulcer healing and relieve symptoms by reducing gastric acid secretion, protecting gastric mucosa, eradicating Helicobacter pylori or neutralizing gastric acid.
The global Peptic Ulcer Disease Medication market size was estimated at USD 5782.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Peptic Ulcer Disease Medication market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Peptic Ulcer Disease Medication market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peptic Ulcer Disease Medication market.
Global Peptic Ulcer Disease Medication Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer
Pfizer
Teva
Takeda
AstraZeneca
Sun Pharma
Mylan
Eisai Co.
CTTQ
Livzon Pharmaceutical
Eastchina Pharma
Luoxin Pharma
Jumpcan Pharmaceutical
AOSAIKANG Pharma
Jiangsu Aosaikang Pharmaceutical
Youcare Pharmaceutical
Zhejiang Conba Pharmaceutical
Chongqing Lummy Pharmaceutical
Market Segmentation (by Type)
Acid-suppressing Drugs (Proton Pump Inhibitors, H2 Receptor Antagonists, etc.)
Mucosal Protective Agents (Bismuth, Sucralfate, etc.)
Antacids (Aluminum Hydroxide, Magnesium Hydroxide, etc.)
Anti-Helicobacter Pylori Drugs
Others
Market Segmentation (by Application)
Hospitals and Clinics
Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peptic Ulcer Disease Medication Market
Overview of the regional outlook of the Peptic Ulcer Disease Medication Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptic Ulcer Disease Medication Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peptic Ulcer Disease Medication, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Peptic Ulcer Disease Medication market size was estimated at USD 5782.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Peptic Ulcer Disease Medication market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Peptic Ulcer Disease Medication market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peptic Ulcer Disease Medication market.
Global Peptic Ulcer Disease Medication Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer
Pfizer
Teva
Takeda
AstraZeneca
Sun Pharma
Mylan
Eisai Co.
CTTQ
Livzon Pharmaceutical
Eastchina Pharma
Luoxin Pharma
Jumpcan Pharmaceutical
AOSAIKANG Pharma
Jiangsu Aosaikang Pharmaceutical
Youcare Pharmaceutical
Zhejiang Conba Pharmaceutical
Chongqing Lummy Pharmaceutical
Market Segmentation (by Type)
Acid-suppressing Drugs (Proton Pump Inhibitors, H2 Receptor Antagonists, etc.)
Mucosal Protective Agents (Bismuth, Sucralfate, etc.)
Antacids (Aluminum Hydroxide, Magnesium Hydroxide, etc.)
Anti-Helicobacter Pylori Drugs
Others
Market Segmentation (by Application)
Hospitals and Clinics
Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peptic Ulcer Disease Medication Market
Overview of the regional outlook of the Peptic Ulcer Disease Medication Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptic Ulcer Disease Medication Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peptic Ulcer Disease Medication, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Peptic Ulcer Disease Medication
1.2 Key Market Segments
1.2.1 Peptic Ulcer Disease Medication Segment by Type
1.2.2 Peptic Ulcer Disease Medication Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PEPTIC ULCER DISEASE MEDICATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peptic Ulcer Disease Medication Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Peptic Ulcer Disease Medication Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PEPTIC ULCER DISEASE MEDICATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peptic Ulcer Disease Medication Product Life Cycle
3.3 Global Peptic Ulcer Disease Medication Sales by Manufacturers (2020-2025)
3.4 Global Peptic Ulcer Disease Medication Revenue Market Share by Manufacturers (2020-2025)
3.5 Peptic Ulcer Disease Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peptic Ulcer Disease Medication Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Peptic Ulcer Disease Medication Market Competitive Situation and Trends
3.8.1 Peptic Ulcer Disease Medication Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peptic Ulcer Disease Medication Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PEPTIC ULCER DISEASE MEDICATION INDUSTRY CHAIN ANALYSIS
4.1 Peptic Ulcer Disease Medication Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PEPTIC ULCER DISEASE MEDICATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peptic Ulcer Disease Medication Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Peptic Ulcer Disease Medication Market
5.7 ESG Ratings of Leading Companies
6 PEPTIC ULCER DISEASE MEDICATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptic Ulcer Disease Medication Sales Market Share by Type (2020-2025)
6.3 Global Peptic Ulcer Disease Medication Market Size by Type (2020-2025)
6.4 Global Peptic Ulcer Disease Medication Price by Type (2020-2025)
7 PEPTIC ULCER DISEASE MEDICATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptic Ulcer Disease Medication Market Sales by Application (2020-2025)
7.3 Global Peptic Ulcer Disease Medication Market Size (M USD) by Application (2020-2025)
7.4 Global Peptic Ulcer Disease Medication Sales Growth Rate by Application (2020-2025)
8 PEPTIC ULCER DISEASE MEDICATION MARKET SALES BY REGION
8.1 Global Peptic Ulcer Disease Medication Sales by Region
8.1.1 Global Peptic Ulcer Disease Medication Sales by Region
8.1.2 Global Peptic Ulcer Disease Medication Sales Market Share by Region
8.2 Global Peptic Ulcer Disease Medication Market Size by Region
8.2.1 Global Peptic Ulcer Disease Medication Market Size by Region
8.2.2 Global Peptic Ulcer Disease Medication Market Size by Region
8.3 North America
8.3.1 North America Peptic Ulcer Disease Medication Sales by Country
8.3.2 North America Peptic Ulcer Disease Medication Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Peptic Ulcer Disease Medication Sales by Country
8.4.2 Europe Peptic Ulcer Disease Medication Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Peptic Ulcer Disease Medication Sales by Region
8.5.2 Asia Pacific Peptic Ulcer Disease Medication Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Peptic Ulcer Disease Medication Sales by Country
8.6.2 South America Peptic Ulcer Disease Medication Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Peptic Ulcer Disease Medication Sales by Region
8.7.2 Middle East and Africa Peptic Ulcer Disease Medication Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PEPTIC ULCER DISEASE MEDICATION MARKET PRODUCTION BY REGION
9.1 Global Production of Peptic Ulcer Disease Medication by Region(2020-2025)
9.2 Global Peptic Ulcer Disease Medication Revenue Market Share by Region (2020-2025)
9.3 Global Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peptic Ulcer Disease Medication Production
9.4.1 North America Peptic Ulcer Disease Medication Production Growth Rate (2020-2025)
9.4.2 North America Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peptic Ulcer Disease Medication Production
9.5.1 Europe Peptic Ulcer Disease Medication Production Growth Rate (2020-2025)
9.5.2 Europe Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peptic Ulcer Disease Medication Production (2020-2025)
9.6.1 Japan Peptic Ulcer Disease Medication Production Growth Rate (2020-2025)
9.6.2 Japan Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peptic Ulcer Disease Medication Production (2020-2025)
9.7.1 China Peptic Ulcer Disease Medication Production Growth Rate (2020-2025)
9.7.2 China Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Peptic Ulcer Disease Medication Product Overview
10.1.3 Bayer Peptic Ulcer Disease Medication Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Pfizer
10.2.1 Pfizer Basic Information
10.2.2 Pfizer Peptic Ulcer Disease Medication Product Overview
10.2.3 Pfizer Peptic Ulcer Disease Medication Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Teva
10.3.1 Teva Basic Information
10.3.2 Teva Peptic Ulcer Disease Medication Product Overview
10.3.3 Teva Peptic Ulcer Disease Medication Product Market Performance
10.3.4 Teva Business Overview
10.3.5 Teva SWOT Analysis
10.3.6 Teva Recent Developments
10.4 Takeda
10.4.1 Takeda Basic Information
10.4.2 Takeda Peptic Ulcer Disease Medication Product Overview
10.4.3 Takeda Peptic Ulcer Disease Medication Product Market Performance
10.4.4 Takeda Business Overview
10.4.5 Takeda Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Peptic Ulcer Disease Medication Product Overview
10.5.3 AstraZeneca Peptic Ulcer Disease Medication Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Sun Pharma
10.6.1 Sun Pharma Basic Information
10.6.2 Sun Pharma Peptic Ulcer Disease Medication Product Overview
10.6.3 Sun Pharma Peptic Ulcer Disease Medication Product Market Performance
10.6.4 Sun Pharma Business Overview
10.6.5 Sun Pharma Recent Developments
10.7 Mylan
10.7.1 Mylan Basic Information
10.7.2 Mylan Peptic Ulcer Disease Medication Product Overview
10.7.3 Mylan Peptic Ulcer Disease Medication Product Market Performance
10.7.4 Mylan Business Overview
10.7.5 Mylan Recent Developments
10.8 Eisai Co.
10.8.1 Eisai Co. Basic Information
10.8.2 Eisai Co. Peptic Ulcer Disease Medication Product Overview
10.8.3 Eisai Co. Peptic Ulcer Disease Medication Product Market Performance
10.8.4 Eisai Co. Business Overview
10.8.5 Eisai Co. Recent Developments
10.9 CTTQ
10.9.1 CTTQ Basic Information
10.9.2 CTTQ Peptic Ulcer Disease Medication Product Overview
10.9.3 CTTQ Peptic Ulcer Disease Medication Product Market Performance
10.9.4 CTTQ Business Overview
10.9.5 CTTQ Recent Developments
10.10 Livzon Pharmaceutical
10.10.1 Livzon Pharmaceutical Basic Information
10.10.2 Livzon Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.10.3 Livzon Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.10.4 Livzon Pharmaceutical Business Overview
10.10.5 Livzon Pharmaceutical Recent Developments
10.11 Eastchina Pharma
10.11.1 Eastchina Pharma Basic Information
10.11.2 Eastchina Pharma Peptic Ulcer Disease Medication Product Overview
10.11.3 Eastchina Pharma Peptic Ulcer Disease Medication Product Market Performance
10.11.4 Eastchina Pharma Business Overview
10.11.5 Eastchina Pharma Recent Developments
10.12 Luoxin Pharma
10.12.1 Luoxin Pharma Basic Information
10.12.2 Luoxin Pharma Peptic Ulcer Disease Medication Product Overview
10.12.3 Luoxin Pharma Peptic Ulcer Disease Medication Product Market Performance
10.12.4 Luoxin Pharma Business Overview
10.12.5 Luoxin Pharma Recent Developments
10.13 Jumpcan Pharmaceutical
10.13.1 Jumpcan Pharmaceutical Basic Information
10.13.2 Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.13.3 Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.13.4 Jumpcan Pharmaceutical Business Overview
10.13.5 Jumpcan Pharmaceutical Recent Developments
10.14 AOSAIKANG Pharma
10.14.1 AOSAIKANG Pharma Basic Information
10.14.2 AOSAIKANG Pharma Peptic Ulcer Disease Medication Product Overview
10.14.3 AOSAIKANG Pharma Peptic Ulcer Disease Medication Product Market Performance
10.14.4 AOSAIKANG Pharma Business Overview
10.14.5 AOSAIKANG Pharma Recent Developments
10.15 Jiangsu Aosaikang Pharmaceutical
10.15.1 Jiangsu Aosaikang Pharmaceutical Basic Information
10.15.2 Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.15.3 Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.15.4 Jiangsu Aosaikang Pharmaceutical Business Overview
10.15.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
10.16 Youcare Pharmaceutical
10.16.1 Youcare Pharmaceutical Basic Information
10.16.2 Youcare Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.16.3 Youcare Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.16.4 Youcare Pharmaceutical Business Overview
10.16.5 Youcare Pharmaceutical Recent Developments
10.17 Zhejiang Conba Pharmaceutical
10.17.1 Zhejiang Conba Pharmaceutical Basic Information
10.17.2 Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.17.3 Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.17.4 Zhejiang Conba Pharmaceutical Business Overview
10.17.5 Zhejiang Conba Pharmaceutical Recent Developments
10.18 Chongqing Lummy Pharmaceutical
10.18.1 Chongqing Lummy Pharmaceutical Basic Information
10.18.2 Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.18.3 Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.18.4 Chongqing Lummy Pharmaceutical Business Overview
10.18.5 Chongqing Lummy Pharmaceutical Recent Developments
11 PEPTIC ULCER DISEASE MEDICATION MARKET FORECAST BY REGION
11.1 Global Peptic Ulcer Disease Medication Market Size Forecast
11.2 Global Peptic Ulcer Disease Medication Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peptic Ulcer Disease Medication Market Size Forecast by Country
11.2.3 Asia Pacific Peptic Ulcer Disease Medication Market Size Forecast by Region
11.2.4 South America Peptic Ulcer Disease Medication Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Peptic Ulcer Disease Medication by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Peptic Ulcer Disease Medication Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Peptic Ulcer Disease Medication by Type (2026-2035)
12.1.2 Global Peptic Ulcer Disease Medication Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Peptic Ulcer Disease Medication by Type (2026-2035)
12.2 Global Peptic Ulcer Disease Medication Market Forecast by Application (2026-2035)
12.2.1 Global Peptic Ulcer Disease Medication Sales (K MT) Forecast by Application
12.2.2 Global Peptic Ulcer Disease Medication Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Peptic Ulcer Disease Medication
1.2 Key Market Segments
1.2.1 Peptic Ulcer Disease Medication Segment by Type
1.2.2 Peptic Ulcer Disease Medication Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PEPTIC ULCER DISEASE MEDICATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peptic Ulcer Disease Medication Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Peptic Ulcer Disease Medication Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PEPTIC ULCER DISEASE MEDICATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peptic Ulcer Disease Medication Product Life Cycle
3.3 Global Peptic Ulcer Disease Medication Sales by Manufacturers (2020-2025)
3.4 Global Peptic Ulcer Disease Medication Revenue Market Share by Manufacturers (2020-2025)
3.5 Peptic Ulcer Disease Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peptic Ulcer Disease Medication Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Peptic Ulcer Disease Medication Market Competitive Situation and Trends
3.8.1 Peptic Ulcer Disease Medication Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peptic Ulcer Disease Medication Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PEPTIC ULCER DISEASE MEDICATION INDUSTRY CHAIN ANALYSIS
4.1 Peptic Ulcer Disease Medication Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PEPTIC ULCER DISEASE MEDICATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peptic Ulcer Disease Medication Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Peptic Ulcer Disease Medication Market
5.7 ESG Ratings of Leading Companies
6 PEPTIC ULCER DISEASE MEDICATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptic Ulcer Disease Medication Sales Market Share by Type (2020-2025)
6.3 Global Peptic Ulcer Disease Medication Market Size by Type (2020-2025)
6.4 Global Peptic Ulcer Disease Medication Price by Type (2020-2025)
7 PEPTIC ULCER DISEASE MEDICATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptic Ulcer Disease Medication Market Sales by Application (2020-2025)
7.3 Global Peptic Ulcer Disease Medication Market Size (M USD) by Application (2020-2025)
7.4 Global Peptic Ulcer Disease Medication Sales Growth Rate by Application (2020-2025)
8 PEPTIC ULCER DISEASE MEDICATION MARKET SALES BY REGION
8.1 Global Peptic Ulcer Disease Medication Sales by Region
8.1.1 Global Peptic Ulcer Disease Medication Sales by Region
8.1.2 Global Peptic Ulcer Disease Medication Sales Market Share by Region
8.2 Global Peptic Ulcer Disease Medication Market Size by Region
8.2.1 Global Peptic Ulcer Disease Medication Market Size by Region
8.2.2 Global Peptic Ulcer Disease Medication Market Size by Region
8.3 North America
8.3.1 North America Peptic Ulcer Disease Medication Sales by Country
8.3.2 North America Peptic Ulcer Disease Medication Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Peptic Ulcer Disease Medication Sales by Country
8.4.2 Europe Peptic Ulcer Disease Medication Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Peptic Ulcer Disease Medication Sales by Region
8.5.2 Asia Pacific Peptic Ulcer Disease Medication Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Peptic Ulcer Disease Medication Sales by Country
8.6.2 South America Peptic Ulcer Disease Medication Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Peptic Ulcer Disease Medication Sales by Region
8.7.2 Middle East and Africa Peptic Ulcer Disease Medication Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PEPTIC ULCER DISEASE MEDICATION MARKET PRODUCTION BY REGION
9.1 Global Production of Peptic Ulcer Disease Medication by Region(2020-2025)
9.2 Global Peptic Ulcer Disease Medication Revenue Market Share by Region (2020-2025)
9.3 Global Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peptic Ulcer Disease Medication Production
9.4.1 North America Peptic Ulcer Disease Medication Production Growth Rate (2020-2025)
9.4.2 North America Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peptic Ulcer Disease Medication Production
9.5.1 Europe Peptic Ulcer Disease Medication Production Growth Rate (2020-2025)
9.5.2 Europe Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peptic Ulcer Disease Medication Production (2020-2025)
9.6.1 Japan Peptic Ulcer Disease Medication Production Growth Rate (2020-2025)
9.6.2 Japan Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peptic Ulcer Disease Medication Production (2020-2025)
9.7.1 China Peptic Ulcer Disease Medication Production Growth Rate (2020-2025)
9.7.2 China Peptic Ulcer Disease Medication Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Peptic Ulcer Disease Medication Product Overview
10.1.3 Bayer Peptic Ulcer Disease Medication Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Pfizer
10.2.1 Pfizer Basic Information
10.2.2 Pfizer Peptic Ulcer Disease Medication Product Overview
10.2.3 Pfizer Peptic Ulcer Disease Medication Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Teva
10.3.1 Teva Basic Information
10.3.2 Teva Peptic Ulcer Disease Medication Product Overview
10.3.3 Teva Peptic Ulcer Disease Medication Product Market Performance
10.3.4 Teva Business Overview
10.3.5 Teva SWOT Analysis
10.3.6 Teva Recent Developments
10.4 Takeda
10.4.1 Takeda Basic Information
10.4.2 Takeda Peptic Ulcer Disease Medication Product Overview
10.4.3 Takeda Peptic Ulcer Disease Medication Product Market Performance
10.4.4 Takeda Business Overview
10.4.5 Takeda Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Peptic Ulcer Disease Medication Product Overview
10.5.3 AstraZeneca Peptic Ulcer Disease Medication Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Sun Pharma
10.6.1 Sun Pharma Basic Information
10.6.2 Sun Pharma Peptic Ulcer Disease Medication Product Overview
10.6.3 Sun Pharma Peptic Ulcer Disease Medication Product Market Performance
10.6.4 Sun Pharma Business Overview
10.6.5 Sun Pharma Recent Developments
10.7 Mylan
10.7.1 Mylan Basic Information
10.7.2 Mylan Peptic Ulcer Disease Medication Product Overview
10.7.3 Mylan Peptic Ulcer Disease Medication Product Market Performance
10.7.4 Mylan Business Overview
10.7.5 Mylan Recent Developments
10.8 Eisai Co.
10.8.1 Eisai Co. Basic Information
10.8.2 Eisai Co. Peptic Ulcer Disease Medication Product Overview
10.8.3 Eisai Co. Peptic Ulcer Disease Medication Product Market Performance
10.8.4 Eisai Co. Business Overview
10.8.5 Eisai Co. Recent Developments
10.9 CTTQ
10.9.1 CTTQ Basic Information
10.9.2 CTTQ Peptic Ulcer Disease Medication Product Overview
10.9.3 CTTQ Peptic Ulcer Disease Medication Product Market Performance
10.9.4 CTTQ Business Overview
10.9.5 CTTQ Recent Developments
10.10 Livzon Pharmaceutical
10.10.1 Livzon Pharmaceutical Basic Information
10.10.2 Livzon Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.10.3 Livzon Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.10.4 Livzon Pharmaceutical Business Overview
10.10.5 Livzon Pharmaceutical Recent Developments
10.11 Eastchina Pharma
10.11.1 Eastchina Pharma Basic Information
10.11.2 Eastchina Pharma Peptic Ulcer Disease Medication Product Overview
10.11.3 Eastchina Pharma Peptic Ulcer Disease Medication Product Market Performance
10.11.4 Eastchina Pharma Business Overview
10.11.5 Eastchina Pharma Recent Developments
10.12 Luoxin Pharma
10.12.1 Luoxin Pharma Basic Information
10.12.2 Luoxin Pharma Peptic Ulcer Disease Medication Product Overview
10.12.3 Luoxin Pharma Peptic Ulcer Disease Medication Product Market Performance
10.12.4 Luoxin Pharma Business Overview
10.12.5 Luoxin Pharma Recent Developments
10.13 Jumpcan Pharmaceutical
10.13.1 Jumpcan Pharmaceutical Basic Information
10.13.2 Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.13.3 Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.13.4 Jumpcan Pharmaceutical Business Overview
10.13.5 Jumpcan Pharmaceutical Recent Developments
10.14 AOSAIKANG Pharma
10.14.1 AOSAIKANG Pharma Basic Information
10.14.2 AOSAIKANG Pharma Peptic Ulcer Disease Medication Product Overview
10.14.3 AOSAIKANG Pharma Peptic Ulcer Disease Medication Product Market Performance
10.14.4 AOSAIKANG Pharma Business Overview
10.14.5 AOSAIKANG Pharma Recent Developments
10.15 Jiangsu Aosaikang Pharmaceutical
10.15.1 Jiangsu Aosaikang Pharmaceutical Basic Information
10.15.2 Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.15.3 Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.15.4 Jiangsu Aosaikang Pharmaceutical Business Overview
10.15.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
10.16 Youcare Pharmaceutical
10.16.1 Youcare Pharmaceutical Basic Information
10.16.2 Youcare Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.16.3 Youcare Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.16.4 Youcare Pharmaceutical Business Overview
10.16.5 Youcare Pharmaceutical Recent Developments
10.17 Zhejiang Conba Pharmaceutical
10.17.1 Zhejiang Conba Pharmaceutical Basic Information
10.17.2 Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.17.3 Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.17.4 Zhejiang Conba Pharmaceutical Business Overview
10.17.5 Zhejiang Conba Pharmaceutical Recent Developments
10.18 Chongqing Lummy Pharmaceutical
10.18.1 Chongqing Lummy Pharmaceutical Basic Information
10.18.2 Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Product Overview
10.18.3 Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Product Market Performance
10.18.4 Chongqing Lummy Pharmaceutical Business Overview
10.18.5 Chongqing Lummy Pharmaceutical Recent Developments
11 PEPTIC ULCER DISEASE MEDICATION MARKET FORECAST BY REGION
11.1 Global Peptic Ulcer Disease Medication Market Size Forecast
11.2 Global Peptic Ulcer Disease Medication Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peptic Ulcer Disease Medication Market Size Forecast by Country
11.2.3 Asia Pacific Peptic Ulcer Disease Medication Market Size Forecast by Region
11.2.4 South America Peptic Ulcer Disease Medication Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Peptic Ulcer Disease Medication by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Peptic Ulcer Disease Medication Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Peptic Ulcer Disease Medication by Type (2026-2035)
12.1.2 Global Peptic Ulcer Disease Medication Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Peptic Ulcer Disease Medication by Type (2026-2035)
12.2 Global Peptic Ulcer Disease Medication Market Forecast by Application (2026-2035)
12.2.1 Global Peptic Ulcer Disease Medication Sales (K MT) Forecast by Application
12.2.2 Global Peptic Ulcer Disease Medication Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peptic Ulcer Disease Medication Market Size by Type (M USD)
Table 4. Global Peptic Ulcer Disease Medication Market Size by Application
Table 5. Peptic Ulcer Disease Medication Market Size Comparison by Region (M USD)
Table 6. Global Peptic Ulcer Disease Medication Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Peptic Ulcer Disease Medication Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peptic Ulcer Disease Medication Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peptic Ulcer Disease Medication Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptic Ulcer Disease Medication as of 2025)
Table 11. Global Market Peptic Ulcer Disease Medication Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Peptic Ulcer Disease Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptic Ulcer Disease Medication Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Peptic Ulcer Disease Medication Sales by Type (K MT)
Table 27. Global Peptic Ulcer Disease Medication Market Size by Type (M USD)
Table 28. Global Peptic Ulcer Disease Medication Sales (K MT) by Type (2020-2025)
Table 29. Global Peptic Ulcer Disease Medication Sales Market Share by Type (2020-2025)
Table 30. Global Peptic Ulcer Disease Medication Market Size (M USD) by Type (2020-2025)
Table 31. Global Peptic Ulcer Disease Medication Market Share by Type (2020-2025)
Table 32. Global Peptic Ulcer Disease Medication Price (USD/KG) by Type (2020-2025)
Table 33. Global Peptic Ulcer Disease Medication Sales (K MT) by Application
Table 34. Global Peptic Ulcer Disease Medication Market Size by Application
Table 35. Global Peptic Ulcer Disease Medication Sales by Application (2020-2025) & (K MT)
Table 36. Global Peptic Ulcer Disease Medication Sales Market Share by Application (2020-2025)
Table 37. Global Peptic Ulcer Disease Medication Market Size by Application (2020-2025) & (M USD)
Table 38. Global Peptic Ulcer Disease Medication Market Share by Application (2020-2025)
Table 39. Global Peptic Ulcer Disease Medication Sales Growth Rate by Application (2020-2025)
Table 40. Global Peptic Ulcer Disease Medication Sales by Region (2020-2025) & (K MT)
Table 41. Global Peptic Ulcer Disease Medication Sales Market Share by Region (2020-2025)
Table 42. Global Peptic Ulcer Disease Medication Market Size by Region (2020-2025) & (M USD)
Table 43. Global Peptic Ulcer Disease Medication Market Size by Region (2020-2025)
Table 44. North America Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K MT)
Table 45. North America Peptic Ulcer Disease Medication Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K MT)
Table 47. Europe Peptic Ulcer Disease Medication Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Peptic Ulcer Disease Medication Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Peptic Ulcer Disease Medication Market Size by Region (2020-2025) & (M USD)
Table 50. South America Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K MT)
Table 51. South America Peptic Ulcer Disease Medication Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Peptic Ulcer Disease Medication Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Peptic Ulcer Disease Medication Market Size by Region (2020-2025) & (M USD)
Table 54. Global Peptic Ulcer Disease Medication Production (K MT) by Region(2020-2025)
Table 55. Global Peptic Ulcer Disease Medication Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Peptic Ulcer Disease Medication Revenue Market Share by Region (2020-2025)
Table 57. Global Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Peptic Ulcer Disease Medication Product Overview
Table 64. Bayer Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Pfizer Basic Information
Table 69. Pfizer Peptic Ulcer Disease Medication Product Overview
Table 70. Pfizer Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Pfizer Business Overview
Table 72. Pfizer SWOT Analysis
Table 73. Pfizer Recent Developments
Table 74. Teva Basic Information
Table 75. Teva Peptic Ulcer Disease Medication Product Overview
Table 76. Teva Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Teva Business Overview
Table 78. Teva SWOT Analysis
Table 79. Teva Recent Developments
Table 80. Takeda Basic Information
Table 81. Takeda Peptic Ulcer Disease Medication Product Overview
Table 82. Takeda Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Takeda Business Overview
Table 84. Takeda Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca Peptic Ulcer Disease Medication Product Overview
Table 87. AstraZeneca Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Sun Pharma Basic Information
Table 91. Sun Pharma Peptic Ulcer Disease Medication Product Overview
Table 92. Sun Pharma Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sun Pharma Business Overview
Table 94. Sun Pharma Recent Developments
Table 95. Mylan Basic Information
Table 96. Mylan Peptic Ulcer Disease Medication Product Overview
Table 97. Mylan Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Mylan Business Overview
Table 99. Mylan Recent Developments
Table 100. Eisai Co. Basic Information
Table 101. Eisai Co. Peptic Ulcer Disease Medication Product Overview
Table 102. Eisai Co. Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Eisai Co. Business Overview
Table 104. Eisai Co. Recent Developments
Table 105. CTTQ Basic Information
Table 106. CTTQ Peptic Ulcer Disease Medication Product Overview
Table 107. CTTQ Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. CTTQ Business Overview
Table 109. CTTQ Recent Developments
Table 110. Livzon Pharmaceutical Basic Information
Table 111. Livzon Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 112. Livzon Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Livzon Pharmaceutical Business Overview
Table 114. Livzon Pharmaceutical Recent Developments
Table 115. Eastchina Pharma Basic Information
Table 116. Eastchina Pharma Peptic Ulcer Disease Medication Product Overview
Table 117. Eastchina Pharma Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Eastchina Pharma Business Overview
Table 119. Eastchina Pharma Recent Developments
Table 120. Luoxin Pharma Basic Information
Table 121. Luoxin Pharma Peptic Ulcer Disease Medication Product Overview
Table 122. Luoxin Pharma Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Luoxin Pharma Business Overview
Table 124. Luoxin Pharma Recent Developments
Table 125. Jumpcan Pharmaceutical Basic Information
Table 126. Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 127. Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Jumpcan Pharmaceutical Business Overview
Table 129. Jumpcan Pharmaceutical Recent Developments
Table 130. AOSAIKANG Pharma Basic Information
Table 131. AOSAIKANG Pharma Peptic Ulcer Disease Medication Product Overview
Table 132. AOSAIKANG Pharma Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. AOSAIKANG Pharma Business Overview
Table 134. AOSAIKANG Pharma Recent Developments
Table 135. Jiangsu Aosaikang Pharmaceutical Basic Information
Table 136. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 137. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 139. Jiangsu Aosaikang Pharmaceutical Recent Developments
Table 140. Youcare Pharmaceutical Basic Information
Table 141. Youcare Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 142. Youcare Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Youcare Pharmaceutical Business Overview
Table 144. Youcare Pharmaceutical Recent Developments
Table 145. Zhejiang Conba Pharmaceutical Basic Information
Table 146. Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 147. Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Zhejiang Conba Pharmaceutical Business Overview
Table 149. Zhejiang Conba Pharmaceutical Recent Developments
Table 150. Chongqing Lummy Pharmaceutical Basic Information
Table 151. Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 152. Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Chongqing Lummy Pharmaceutical Business Overview
Table 154. Chongqing Lummy Pharmaceutical Recent Developments
Table 155. Global Peptic Ulcer Disease Medication Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Peptic Ulcer Disease Medication Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Peptic Ulcer Disease Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Peptic Ulcer Disease Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Peptic Ulcer Disease Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Peptic Ulcer Disease Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Peptic Ulcer Disease Medication Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Peptic Ulcer Disease Medication Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Peptic Ulcer Disease Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Peptic Ulcer Disease Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Peptic Ulcer Disease Medication Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Peptic Ulcer Disease Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Peptic Ulcer Disease Medication Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Peptic Ulcer Disease Medication Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Peptic Ulcer Disease Medication Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Peptic Ulcer Disease Medication Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Peptic Ulcer Disease Medication Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peptic Ulcer Disease Medication Market Size by Type (M USD)
Table 4. Global Peptic Ulcer Disease Medication Market Size by Application
Table 5. Peptic Ulcer Disease Medication Market Size Comparison by Region (M USD)
Table 6. Global Peptic Ulcer Disease Medication Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Peptic Ulcer Disease Medication Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peptic Ulcer Disease Medication Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peptic Ulcer Disease Medication Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptic Ulcer Disease Medication as of 2025)
Table 11. Global Market Peptic Ulcer Disease Medication Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Peptic Ulcer Disease Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptic Ulcer Disease Medication Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Peptic Ulcer Disease Medication Sales by Type (K MT)
Table 27. Global Peptic Ulcer Disease Medication Market Size by Type (M USD)
Table 28. Global Peptic Ulcer Disease Medication Sales (K MT) by Type (2020-2025)
Table 29. Global Peptic Ulcer Disease Medication Sales Market Share by Type (2020-2025)
Table 30. Global Peptic Ulcer Disease Medication Market Size (M USD) by Type (2020-2025)
Table 31. Global Peptic Ulcer Disease Medication Market Share by Type (2020-2025)
Table 32. Global Peptic Ulcer Disease Medication Price (USD/KG) by Type (2020-2025)
Table 33. Global Peptic Ulcer Disease Medication Sales (K MT) by Application
Table 34. Global Peptic Ulcer Disease Medication Market Size by Application
Table 35. Global Peptic Ulcer Disease Medication Sales by Application (2020-2025) & (K MT)
Table 36. Global Peptic Ulcer Disease Medication Sales Market Share by Application (2020-2025)
Table 37. Global Peptic Ulcer Disease Medication Market Size by Application (2020-2025) & (M USD)
Table 38. Global Peptic Ulcer Disease Medication Market Share by Application (2020-2025)
Table 39. Global Peptic Ulcer Disease Medication Sales Growth Rate by Application (2020-2025)
Table 40. Global Peptic Ulcer Disease Medication Sales by Region (2020-2025) & (K MT)
Table 41. Global Peptic Ulcer Disease Medication Sales Market Share by Region (2020-2025)
Table 42. Global Peptic Ulcer Disease Medication Market Size by Region (2020-2025) & (M USD)
Table 43. Global Peptic Ulcer Disease Medication Market Size by Region (2020-2025)
Table 44. North America Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K MT)
Table 45. North America Peptic Ulcer Disease Medication Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K MT)
Table 47. Europe Peptic Ulcer Disease Medication Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Peptic Ulcer Disease Medication Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Peptic Ulcer Disease Medication Market Size by Region (2020-2025) & (M USD)
Table 50. South America Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K MT)
Table 51. South America Peptic Ulcer Disease Medication Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Peptic Ulcer Disease Medication Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Peptic Ulcer Disease Medication Market Size by Region (2020-2025) & (M USD)
Table 54. Global Peptic Ulcer Disease Medication Production (K MT) by Region(2020-2025)
Table 55. Global Peptic Ulcer Disease Medication Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Peptic Ulcer Disease Medication Revenue Market Share by Region (2020-2025)
Table 57. Global Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Peptic Ulcer Disease Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Peptic Ulcer Disease Medication Product Overview
Table 64. Bayer Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Pfizer Basic Information
Table 69. Pfizer Peptic Ulcer Disease Medication Product Overview
Table 70. Pfizer Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Pfizer Business Overview
Table 72. Pfizer SWOT Analysis
Table 73. Pfizer Recent Developments
Table 74. Teva Basic Information
Table 75. Teva Peptic Ulcer Disease Medication Product Overview
Table 76. Teva Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Teva Business Overview
Table 78. Teva SWOT Analysis
Table 79. Teva Recent Developments
Table 80. Takeda Basic Information
Table 81. Takeda Peptic Ulcer Disease Medication Product Overview
Table 82. Takeda Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Takeda Business Overview
Table 84. Takeda Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca Peptic Ulcer Disease Medication Product Overview
Table 87. AstraZeneca Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Sun Pharma Basic Information
Table 91. Sun Pharma Peptic Ulcer Disease Medication Product Overview
Table 92. Sun Pharma Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sun Pharma Business Overview
Table 94. Sun Pharma Recent Developments
Table 95. Mylan Basic Information
Table 96. Mylan Peptic Ulcer Disease Medication Product Overview
Table 97. Mylan Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Mylan Business Overview
Table 99. Mylan Recent Developments
Table 100. Eisai Co. Basic Information
Table 101. Eisai Co. Peptic Ulcer Disease Medication Product Overview
Table 102. Eisai Co. Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Eisai Co. Business Overview
Table 104. Eisai Co. Recent Developments
Table 105. CTTQ Basic Information
Table 106. CTTQ Peptic Ulcer Disease Medication Product Overview
Table 107. CTTQ Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. CTTQ Business Overview
Table 109. CTTQ Recent Developments
Table 110. Livzon Pharmaceutical Basic Information
Table 111. Livzon Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 112. Livzon Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Livzon Pharmaceutical Business Overview
Table 114. Livzon Pharmaceutical Recent Developments
Table 115. Eastchina Pharma Basic Information
Table 116. Eastchina Pharma Peptic Ulcer Disease Medication Product Overview
Table 117. Eastchina Pharma Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Eastchina Pharma Business Overview
Table 119. Eastchina Pharma Recent Developments
Table 120. Luoxin Pharma Basic Information
Table 121. Luoxin Pharma Peptic Ulcer Disease Medication Product Overview
Table 122. Luoxin Pharma Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Luoxin Pharma Business Overview
Table 124. Luoxin Pharma Recent Developments
Table 125. Jumpcan Pharmaceutical Basic Information
Table 126. Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 127. Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Jumpcan Pharmaceutical Business Overview
Table 129. Jumpcan Pharmaceutical Recent Developments
Table 130. AOSAIKANG Pharma Basic Information
Table 131. AOSAIKANG Pharma Peptic Ulcer Disease Medication Product Overview
Table 132. AOSAIKANG Pharma Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. AOSAIKANG Pharma Business Overview
Table 134. AOSAIKANG Pharma Recent Developments
Table 135. Jiangsu Aosaikang Pharmaceutical Basic Information
Table 136. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 137. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 139. Jiangsu Aosaikang Pharmaceutical Recent Developments
Table 140. Youcare Pharmaceutical Basic Information
Table 141. Youcare Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 142. Youcare Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Youcare Pharmaceutical Business Overview
Table 144. Youcare Pharmaceutical Recent Developments
Table 145. Zhejiang Conba Pharmaceutical Basic Information
Table 146. Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 147. Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Zhejiang Conba Pharmaceutical Business Overview
Table 149. Zhejiang Conba Pharmaceutical Recent Developments
Table 150. Chongqing Lummy Pharmaceutical Basic Information
Table 151. Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Product Overview
Table 152. Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Chongqing Lummy Pharmaceutical Business Overview
Table 154. Chongqing Lummy Pharmaceutical Recent Developments
Table 155. Global Peptic Ulcer Disease Medication Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Peptic Ulcer Disease Medication Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Peptic Ulcer Disease Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Peptic Ulcer Disease Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Peptic Ulcer Disease Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Peptic Ulcer Disease Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Peptic Ulcer Disease Medication Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Peptic Ulcer Disease Medication Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Peptic Ulcer Disease Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Peptic Ulcer Disease Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Peptic Ulcer Disease Medication Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Peptic Ulcer Disease Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Peptic Ulcer Disease Medication Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Peptic Ulcer Disease Medication Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Peptic Ulcer Disease Medication Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Peptic Ulcer Disease Medication Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Peptic Ulcer Disease Medication Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Peptic Ulcer Disease Medication
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptic Ulcer Disease Medication Market Size (M USD), 2025-2035
Figure 5. Global Peptic Ulcer Disease Medication Market Size (M USD) (2020-2035)
Figure 6. Global Peptic Ulcer Disease Medication Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptic Ulcer Disease Medication Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peptic Ulcer Disease Medication Product Life Cycle
Figure 13. Peptic Ulcer Disease Medication Sales Share by Manufacturers in 2025
Figure 14. Global Peptic Ulcer Disease Medication Revenue Share by Manufacturers in 2025
Figure 15. Peptic Ulcer Disease Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Peptic Ulcer Disease Medication Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peptic Ulcer Disease Medication Revenue in 2025
Figure 18. Industry Chain Map of Peptic Ulcer Disease Medication
Figure 19. Global Peptic Ulcer Disease Medication Market PEST Analysis
Figure 20. Global Peptic Ulcer Disease Medication Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Peptic Ulcer Disease Medication Market Share by Type
Figure 27. Sales Market Share of Peptic Ulcer Disease Medication by Type (2020-2025)
Figure 28. Sales Market Share of Peptic Ulcer Disease Medication by Type in 2025
Figure 29. Market Share of Peptic Ulcer Disease Medication by Type (2020-2025)
Figure 30. Market Share of Peptic Ulcer Disease Medication by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Peptic Ulcer Disease Medication Market Share by Application
Figure 33. Global Peptic Ulcer Disease Medication Sales Market Share by Application (2020-2025)
Figure 34. Global Peptic Ulcer Disease Medication Sales Market Share by Application in 2025
Figure 35. Global Peptic Ulcer Disease Medication Market Share by Application (2020-2025)
Figure 36. Global Peptic Ulcer Disease Medication Market Share by Application in 2025
Figure 37. Global Peptic Ulcer Disease Medication Sales Growth Rate by Application (2020-2025)
Figure 38. Global Peptic Ulcer Disease Medication Sales Market Share by Region (2020-2025)
Figure 39. Global Peptic Ulcer Disease Medication Market Size by Region (2020-2025)
Figure 40. North America Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Peptic Ulcer Disease Medication Sales Market Share by Country in 2024
Figure 43. North America Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Peptic Ulcer Disease Medication Market Size by Country in 2024
Figure 45. U.S. Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Peptic Ulcer Disease Medication Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Peptic Ulcer Disease Medication Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Peptic Ulcer Disease Medication Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Peptic Ulcer Disease Medication Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Peptic Ulcer Disease Medication Sales Market Share by Country in 2024
Figure 53. Europe Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Peptic Ulcer Disease Medication Market Size by Country in 2024
Figure 55. Germany Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Peptic Ulcer Disease Medication Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Peptic Ulcer Disease Medication Sales Market Share by Region in 2024
Figure 67. Asia Pacific Peptic Ulcer Disease Medication Market Size by Region in 2024
Figure 68. China Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Peptic Ulcer Disease Medication Sales and Growth Rate (K MT)
Figure 79. South America Peptic Ulcer Disease Medication Sales Market Share by Country in 2024
Figure 80. South America Peptic Ulcer Disease Medication Market Size and Growth Rate (M USD)
Figure 81. South America Peptic Ulcer Disease Medication Market Size by Country in 2024
Figure 82. Brazil Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Peptic Ulcer Disease Medication Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Peptic Ulcer Disease Medication Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Peptic Ulcer Disease Medication Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Peptic Ulcer Disease Medication Market Size by Region in 2024
Figure 92. Saudi Arabia Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Peptic Ulcer Disease Medication Production Market Share by Region (2020-2025)
Figure 103. North America Peptic Ulcer Disease Medication Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Peptic Ulcer Disease Medication Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Peptic Ulcer Disease Medication Production (K MT) Growth Rate (2020-2025)
Figure 106. China Peptic Ulcer Disease Medication Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Peptic Ulcer Disease Medication Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Peptic Ulcer Disease Medication Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Peptic Ulcer Disease Medication Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Peptic Ulcer Disease Medication Market Share Forecast by Type (2026-2035)
Figure 111. Global Peptic Ulcer Disease Medication Sales Forecast by Application (2026-2035)
Figure 112. Global Peptic Ulcer Disease Medication Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Peptic Ulcer Disease Medication
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptic Ulcer Disease Medication Market Size (M USD), 2025-2035
Figure 5. Global Peptic Ulcer Disease Medication Market Size (M USD) (2020-2035)
Figure 6. Global Peptic Ulcer Disease Medication Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptic Ulcer Disease Medication Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peptic Ulcer Disease Medication Product Life Cycle
Figure 13. Peptic Ulcer Disease Medication Sales Share by Manufacturers in 2025
Figure 14. Global Peptic Ulcer Disease Medication Revenue Share by Manufacturers in 2025
Figure 15. Peptic Ulcer Disease Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Peptic Ulcer Disease Medication Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peptic Ulcer Disease Medication Revenue in 2025
Figure 18. Industry Chain Map of Peptic Ulcer Disease Medication
Figure 19. Global Peptic Ulcer Disease Medication Market PEST Analysis
Figure 20. Global Peptic Ulcer Disease Medication Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Peptic Ulcer Disease Medication Market Share by Type
Figure 27. Sales Market Share of Peptic Ulcer Disease Medication by Type (2020-2025)
Figure 28. Sales Market Share of Peptic Ulcer Disease Medication by Type in 2025
Figure 29. Market Share of Peptic Ulcer Disease Medication by Type (2020-2025)
Figure 30. Market Share of Peptic Ulcer Disease Medication by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Peptic Ulcer Disease Medication Market Share by Application
Figure 33. Global Peptic Ulcer Disease Medication Sales Market Share by Application (2020-2025)
Figure 34. Global Peptic Ulcer Disease Medication Sales Market Share by Application in 2025
Figure 35. Global Peptic Ulcer Disease Medication Market Share by Application (2020-2025)
Figure 36. Global Peptic Ulcer Disease Medication Market Share by Application in 2025
Figure 37. Global Peptic Ulcer Disease Medication Sales Growth Rate by Application (2020-2025)
Figure 38. Global Peptic Ulcer Disease Medication Sales Market Share by Region (2020-2025)
Figure 39. Global Peptic Ulcer Disease Medication Market Size by Region (2020-2025)
Figure 40. North America Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Peptic Ulcer Disease Medication Sales Market Share by Country in 2024
Figure 43. North America Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Peptic Ulcer Disease Medication Market Size by Country in 2024
Figure 45. U.S. Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Peptic Ulcer Disease Medication Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Peptic Ulcer Disease Medication Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Peptic Ulcer Disease Medication Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Peptic Ulcer Disease Medication Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Peptic Ulcer Disease Medication Sales Market Share by Country in 2024
Figure 53. Europe Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Peptic Ulcer Disease Medication Market Size by Country in 2024
Figure 55. Germany Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Peptic Ulcer Disease Medication Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Peptic Ulcer Disease Medication Sales Market Share by Region in 2024
Figure 67. Asia Pacific Peptic Ulcer Disease Medication Market Size by Region in 2024
Figure 68. China Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Peptic Ulcer Disease Medication Sales and Growth Rate (K MT)
Figure 79. South America Peptic Ulcer Disease Medication Sales Market Share by Country in 2024
Figure 80. South America Peptic Ulcer Disease Medication Market Size and Growth Rate (M USD)
Figure 81. South America Peptic Ulcer Disease Medication Market Size by Country in 2024
Figure 82. Brazil Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Peptic Ulcer Disease Medication Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Peptic Ulcer Disease Medication Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Peptic Ulcer Disease Medication Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Peptic Ulcer Disease Medication Market Size by Region in 2024
Figure 92. Saudi Arabia Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Peptic Ulcer Disease Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Peptic Ulcer Disease Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Peptic Ulcer Disease Medication Production Market Share by Region (2020-2025)
Figure 103. North America Peptic Ulcer Disease Medication Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Peptic Ulcer Disease Medication Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Peptic Ulcer Disease Medication Production (K MT) Growth Rate (2020-2025)
Figure 106. China Peptic Ulcer Disease Medication Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Peptic Ulcer Disease Medication Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Peptic Ulcer Disease Medication Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Peptic Ulcer Disease Medication Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Peptic Ulcer Disease Medication Market Share Forecast by Type (2026-2035)
Figure 111. Global Peptic Ulcer Disease Medication Sales Forecast by Application (2026-2035)
Figure 112. Global Peptic Ulcer Disease Medication Market Share Forecast by Application (2026-2035)
